3-aminobenzamide has been researched along with Lupus Erythematosus, Systemic in 1 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, F | 1 |
| Otsuka, F | 1 |
| Enomoto, T | 1 |
| Hanaoka, F | 1 |
| Yamada, M | 1 |
| Kamatani, N | 1 |
| Nakano, K | 1 |
| Matsuta, K | 1 |
| Tanimoto, K | 1 |
| Morita, T | 1 |
1 other study available for 3-aminobenzamide and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Decrease in the reaction of DNA repair synthesis in response to nicotinamide or 3-aminobenzamide in ultraviolet irradiated systemic lupus erythematosus lymphocytes.
Topics: Benzamides; DNA Repair; Humans; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocytes; Nia | 1985 |